BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22261412)

  • 1. Measuring risk online--feasibility of using FINDRISC in an online workplace survey.
    Gyberg V; Hasson D; Tuomilehto J; Rydén L
    Prim Care Diabetes; 2012 Jul; 6(2):103-7. PubMed ID: 22261412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupational health care identifies risk for type 2 diabetes and cardiovascular disease.
    Viitasalo K; Lindström J; Hemiö K; Puttonen S; Koho A; Härmä M; Peltonen M
    Prim Care Diabetes; 2012 Jul; 6(2):95-102. PubMed ID: 22306176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population.
    Bergmann A; Li J; Wang L; Schulze J; Bornstein SR; Schwarz PE
    Horm Metab Res; 2007 Sep; 39(9):677-82. PubMed ID: 17846976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of diabetes and cardiovascular diseases in occupational health care: feasibility and effectiveness.
    Viitasalo K; Hemiö K; Puttonen S; Hyvärinen HK; Leiviskä J; Härmä M; Peltonen M; Lindström J
    Prim Care Diabetes; 2015 Apr; 9(2):96-104. PubMed ID: 25128324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in occupational health care.
    Vandersmissen GJ; Godderis L
    Int J Occup Med Environ Health; 2015; 28(3):587-91. PubMed ID: 26190733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study.
    Lindström J; Peltonen M; Eriksson JG; Aunola S; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Uusitupa M; Tuomilehto J;
    Diabetes Care; 2008 May; 31(5):857-62. PubMed ID: 18252900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Finnish Diabetes Risk Score is associated with insulin resistance but not reduced β-cell function, by classical and model-based estimates.
    Brodovicz KG; Dekker JM; Rijkelijkhuizen JM; Rhodes T; Mari A; Alssema M; Nijpels G; Williams-Herman DE; Girman CJ
    Diabet Med; 2011 Sep; 28(9):1078-81. PubMed ID: 21843304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D).
    Saaristo T; Moilanen L; Jokelainen J; Korpi-Hyövälti E; Vanhala M; Saltevo J; Niskanen L; Peltonen M; Oksa H; Cederberg H; Tuomilehto J; Uusitupa M; Keinänen-Kiukaanniemi S
    Prim Care Diabetes; 2010 Dec; 4(4):231-9. PubMed ID: 21134669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.
    Makrilakis K; Liatis S; Grammatikou S; Perrea D; Stathi C; Tsiligros P; Katsilambros N
    Diabetes Metab; 2011 Apr; 37(2):144-51. PubMed ID: 21144787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different type 2 diabetes risk assessments predict dissimilar numbers at 'high risk': a retrospective analysis of diabetes risk-assessment tools.
    Gray BJ; Bracken RM; Turner D; Morgan K; Thomas M; Williams SP; Williams M; Rice S; Stephens JW;
    Br J Gen Pract; 2015 Dec; 65(641):e852-60. PubMed ID: 26541180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using technology to deliver healthcare education to rural patients.
    McIlhenny CV; Guzic BL; Knee DR; Wendekier CM; Demuth BR; Roberts JB
    Rural Remote Health; 2011; 11(4):1798. PubMed ID: 21995854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of certain health behaviors and conditions among states and selected local areas --- Behavioral Risk Factor Surveillance System, United States, 2009.
    Li C; Balluz LS; Okoro CA; Strine TW; Lin JM; Town M; Garvin W; Murphy W; Bartoli W; Valluru B;
    MMWR Surveill Summ; 2011 Aug; 60(9):1-250. PubMed ID: 21849967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic position and effectiveness of lifestyle intervention in prevention of type 2 diabetes: one-year follow-up of the FIN-D2D project.
    Rautio N; Jokelainen J; Oksa H; Saaristo T; Peltonen M; Niskanen L; Puolijoki H; Vanhala M; Uusitupa M; Keinänen-Kiukaanniemi S;
    Scand J Public Health; 2011 Aug; 39(6):561-70. PubMed ID: 21622677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis.
    Carvalho JA; Barengo NC; Tuomilehto J; Conceição RD; Santos RD
    Ann Med; 2011; 43(6):487-94. PubMed ID: 21604917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of selected risk behaviors and chronic diseases and conditions-steps communities, United States, 2006-2007.
    Cory S; Ussery-Hall A; Griffin-Blake S; Easton A; Vigeant J; Balluz L; Garvin W; Greenlund K;
    MMWR Surveill Summ; 2010 Sep; 59(8):1-37. PubMed ID: 20864923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population.
    Robinson CA; Agarwal G; Nerenberg K
    Chronic Dis Inj Can; 2011 Dec; 32(1):19-31. PubMed ID: 22153173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tools for predicting the risk of type 2 diabetes in daily practice.
    Schwarz PE; Li J; Lindstrom J; Tuomilehto J
    Horm Metab Res; 2009 Feb; 41(2):86-97. PubMed ID: 19021089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in Kayseri, Turkey.
    Atayoglu AT; Inanc N; Başmisirli E; Çapar AG
    Prim Care Diabetes; 2020 Oct; 14(5):488-493. PubMed ID: 32029385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community.
    Harati H; Hadaegh F; Momenan AA; Ghanei L; Bozorgmanesh MR; Ghanbarian A; Mirmiran P; Azizi F
    Am J Prev Med; 2010 Jun; 38(6):628-636.e1. PubMed ID: 20494239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preventive measures against tuberculosis in working facilities and companies].
    Suzuki K; Satou K
    Kekkaku; 2007 Mar; 82(3):201-16. PubMed ID: 17444125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.